The latentiation process in drug design.

Página do item simplificado
dc.contributor.authorChin, C. M.
dc.contributor.authorFerreira, E. I.
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.date.accessioned2020-12-10T18:00:02Z
dc.date.available2020-12-10T18:00:02Z
dc.date.issued1999-01-01
dc.description.abstractShort review about the main aspects of prodrug design, as its objectives, applicability and importance, showing the new trends in the research for selective latent forms, namely targeted drugs.en
dc.description.affiliationUNESP, Fac Ciencias Farmaceut, Dept Farm & Med, BR-14801902 Araraquara, SP, Brazil
dc.description.affiliationUSP, Fac Ciencias Farmaceut, Dept Farm, BR-05389970 Sao Paulo, Brazil
dc.description.affiliationUnespUNESP, Fac Ciencias Farmaceut, Dept Farm & Med, BR-14801902 Araraquara, SP, Brazil
dc.format.extent75-84
dc.identifier.citationQuimica Nova. Sao Paulo: Soc Brasileira Quimica, v. 22, n. 1, p. 75-84, 1999.
dc.identifier.issn0100-4042
dc.identifier.lattes9734333607975413
dc.identifier.orcid0000-0003-4141-0455
dc.identifier.urihttp://hdl.handle.net/11449/195680
dc.identifier.wosWOS:000078164200013
dc.language.isopor
dc.publisherSoc Brasileira Quimica
dc.relation.ispartofQuimica Nova
dc.sourceWeb of Science
dc.subjectlatentiation
dc.subjectmolecular modification
dc.subjectprodrug design
dc.subjectdrug design
dc.titleThe latentiation process in drug design.en
dc.typeResenha
dcterms.rightsHolderSoc Brasileira Quimica
unesp.author.lattes9734333607975413[1]
unesp.author.orcid0000-0003-4141-0455[1]

Arquivos

Coleções

Artigos - Fármacos e Medicamentos - FCFAR